2 results match your criteria: "Medical University of South Carolina Campus. Charleston[Affiliation]"
A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide.
Pharm Pract (Granada)
January 2013
South Carolina College of Pharmacy, Medical University of South Carolina Campus. Charleston, SC (United States).
Background: The potency of intravenous bumetanide to furosemide using a ratio of 1:40 has been suggested; however, there are little data supporting this ratio. Recent drug shortages required the use of bumetanide in a large patient population, enabling further characterization of the efficacy of IV bumetanide.
Objective: The primary objective of this study was to estimate a dose-response effect of IV bumetanide on urine output (UOP) in all patients that received 48 hours of therapy as well as in a subgroup of patients with heart failure (HF).
Evaluation of patient perceptions and outcomes related to anticoagulation point-of-care testing in ambulatory care clinics.
Pharm Pract (Granada)
October 2009
Clinical Assistant Professor. Auburn University Harrison School of Pharmacy, Department of Pharmacy Practice and The University of Alabama School of Medicine, Tuscaloosa, Department of Community and Rural Medicine. Tuscaloosa, AL ( United States ).
Unlabelled: Until recently, Prothrombin Time/International Normalized Ratio (PT/INR) measurements have typically been used to monitor patients on warfarin through institutional laboratories via venous puncture. The Point-of-Care Testing (POCT) device has revolutionized the patient care process by allowing for laboratory testing outside of the central laboratory.
Objective: To analyze humanistic and clinical outcomes in patients currently treated with warfarin and monitored through a pharmacist-managed anticoagulation clinic using point-of-care testing (POCT) device versus venipuncture within ambulatory care clinics at our institution.